mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.3 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.3 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |